144 related articles for article (PubMed ID: 6175308)
1. New simple dye-uptake assay for interferon.
Imanishi J; Hoshino S; Hoshino A; Oku T; Kita M; Kishida T
Biken J; 1981 Sep; 24(3):103-8. PubMed ID: 6175308
[TBL] [Abstract][Full Text] [Related]
2. Assay of human interferon in Vero cells by several methods.
Ferreira PC; Peixoto ML; Silva MA; Golgher RR
J Clin Microbiol; 1979 Apr; 9(4):471-5. PubMed ID: 222803
[TBL] [Abstract][Full Text] [Related]
3. Interferon: enhanced synthesis and action in mouse and human cells under suboptimal growth conditions.
Carter WA
Johns Hopkins Med J; 1972 Mar; 130(3):166-73. PubMed ID: 4110584
[No Abstract] [Full Text] [Related]
4. [Critical study of an assay of human leukocyte and lymphoblastoid interferon on MDBK cells, in microplaque, by the "dye uptake" method. I. Biological factors].
Capellier M; Lévy-Benezra R; Poindron P
Ann Pharm Fr; 1986; 44(3):217-27. PubMed ID: 3026225
[No Abstract] [Full Text] [Related]
5. [Interferon production stimulation in the white mouse by dimethylsulfoxide (DMSO)].
Kunze M; Hofmann H; Klein HJ
Zentralbl Bakteriol Orig; 1971; 216(4):527-31. PubMed ID: 4326011
[No Abstract] [Full Text] [Related]
6. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
Ito Y; Montagnier L
Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
[TBL] [Abstract][Full Text] [Related]
7. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells.
Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM
Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154
[TBL] [Abstract][Full Text] [Related]
8. Microtiter assay for interferon: microspectrophotometric quantitation of cytopathic effect.
McManus NH
Appl Environ Microbiol; 1976 Jan; 31(1):35-8. PubMed ID: 182074
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on the inhibitory effects of interferon on various strains of herpes simplex viruses in vitro.
Imanishi J; Matsubara M; Kishida T; Ozaki Y; Kurimura T
Biken J; 1980 Sep; 23(3):107-11. PubMed ID: 6161604
[TBL] [Abstract][Full Text] [Related]
10. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory.
Yousefi S; Escobar MR; Gouldin CW
Am J Clin Pathol; 1985 Jun; 83(6):735-40. PubMed ID: 2988328
[TBL] [Abstract][Full Text] [Related]
11. A simple and efficient microassay method for titration of interferon.
Ishitsuka H; Nomura Y; Takano K
Microbiol Immunol; 1977 Oct; 21(10):583-91. PubMed ID: 201822
[TBL] [Abstract][Full Text] [Related]
12. Dye uptake assay: an efficient and sensitive method for human interferon titration.
Pidot AL
Appl Microbiol; 1971 Oct; 22(4):671-7. PubMed ID: 4331773
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three bioassays for rat interferon.
Burleson GR; Herzog DP
J Virol Methods; 1984 Oct; 9(2):163-71. PubMed ID: 6210298
[TBL] [Abstract][Full Text] [Related]
14. [More rapid method of microtitration of murine interferons by retarding the cytopathogenic effect of vesicular stomatitis virus].
Pavlushina SV; Orlova TG
Vopr Virusol; 1981; (2):242-3. PubMed ID: 6168118
[No Abstract] [Full Text] [Related]
15. A new assay system for guinea pig interferon biological activity.
Yamamoto T; Jeevan A; Ohishi K; Nojima Y; Umemori K; Yamamoto S; McMurray DN
J Interferon Cytokine Res; 2002 Jul; 22(7):793-7. PubMed ID: 12184917
[TBL] [Abstract][Full Text] [Related]
16. ELISA measurement of interferons.
Garrison TL; Hung F; Izotova L; Schwartz B; Lavoie T; Lee-Own FV
Biotechniques; 2002 Oct; Suppl():98-100. PubMed ID: 12395933
[No Abstract] [Full Text] [Related]
17. Determination of interferon beta neutralizing antibodies in multiple sclerosis: improvement of clinical sensitivity of a cytopathic effect assay.
Massart C; Gibassier J; de Seze J; Debouverie M; Moreau T; Pelletier J; Vermersch P; Edan G
Clin Chim Acta; 2008 May; 391(1-2):98-101. PubMed ID: 18249193
[TBL] [Abstract][Full Text] [Related]
18. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
Wallach D
J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
[TBL] [Abstract][Full Text] [Related]
19. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.
Stojdl DF; Lichty B; Knowles S; Marius R; Atkins H; Sonenberg N; Bell JC
Nat Med; 2000 Jul; 6(7):821-5. PubMed ID: 10888934
[TBL] [Abstract][Full Text] [Related]
20. Convenient assay for interferons.
Rubinstein S; Familletti PC; Pestka S
J Virol; 1981 Feb; 37(2):755-8. PubMed ID: 6163873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
